Inovio receives orphan drug designation from u.s. fda for dna medicine ino-3107 to treat rare disease recurrent respiratory papillomatosis (rrp)

Plymouth meeting, pa., july 29, 2020 /prnewswire/ -- inovio (nasdaq: ino) today announced that the u.s.

INO Ratings Summary

INO Quant Ranking